By Tejas MD There's still plenty to play for in the final stretch of 2026. The Nifty 50 is down around 3% for the year, despite a strong rally over the past month. With just 29 trading sessions left, can it turn things around and keep its 10-year winning streak alive? Inflation isn't making things any easier. Retail inflation hit 6.09% in October, breaching the RBI's upper tolerance limit, while wholesale inflation remains in double digits for a second straight month.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Tejas MD
What superstars bought: New IPOs or old favourites?
By Tejas MD The past month has brought some long awaited relief to investors. The Nifty 50 rose for seven consecutive sessions leading up to the Diwali Muhurat trading session on Sunday. It ended the special session slightly in the red, but who's complaining when the index is still up over 12% in just a month? The earnings season has also been encouraging. Of the 421 Nifty 500 companies that have announced results so far, 311 reported profit growth, with combined revenues rising 21.8%.
Indian IT’s best week since 2008. Is the comeback real?
By Tejas MD The September end earnings season is in full swing, and India’s IPO market is more than keeping pace. The much-anticipated Jio Platforms IPO opened for subscription today, and in a decade of large IPOs, this one is the largest ever at a size of Rs 30,213 crore. But the action isn’t limited to Jio. Reliance Industries is drawing some unusual bets of its own.
After the drop, are stock market valuations finally reasonable?
By Tejas MD The Nifty 50 opened sharply higher on Wednesday, jumping over 3% after the US and Iran agreed to a two week ceasefire, with Iran agreeing to reopen the Strait of Hormuz. The ceasefire is already fragile, after Israel bombed civilian neighborhoods in Lebanon, killing nearly 300 people including children and injuring thousands.
Running strait into trouble: the oil shock hits India hard
By Tejas MD Nifty 50 hasn’t posted a monthly gain since December 2025. Investors continue to wait. Positive events like the Santa rally, the new year and the US trade deal provided brief bumps before fizzling out. The problem isn’t made in India. The challenge for the market is Trumpian, caused first by his tariffs and then his attack on Iran. Oil prices have jumped as the bombs fell, and Iran responded by closing the Strait of Hormuz and cutting the world off from oil and gas supplies.
We tracked 5 years of IPOs. Some hard truths for investors about returns
By Tejas MD Despite all the volatility in financial markets, one trend refuses to slow down: companies lining up for IPOs, to raise new capital or offload stakes. There is no lack of opportunity for investors looking for new offerings. Before one issue closes, two more are waiting in line. The total number of IPO listings has steadily risen over the past five years, and in 2026 big names like NSE, Zepto, and PhonePe are expected to list, keeping the pipeline busy.
The Big Bulls are bleeding: Kacholia and Kedia get a reality check this Q3
By Tejas MD Every time I sit down to write this newsletter, I tell myself: maybe this week Trump won’t be in the news. And every time, Trump offers an all-caps reply: “Thank you for your attention to this matter!” Indian markets jumped sharply on Tuesday after Trump took everyone by surprise by announcing a US-India trade deal. Superstar investor Vijay Kedia responded in his trademark style: with a song.
The top five: Analysts pick their winners for Q3
By Tejas MD Almost immediately after Nifty 50 hit an all-time high on January 5, it lost steam and fell for the next five trading sessions. No prizes for guessing why: it was another of Trump’s tariff tantrums, which have effectively become India’s new macro risk index. FY26 feels like a tug-of-war between fundamentals on one side and trade threats on the other.
Midcap momentum: Index performance beats Nifty 50 and Smallcap
By Tejas MD The Nifty 50 was running in sand this past week. It touched a one-year high of 26,246.7 but then slid back, and struggled to stay above the psychological 26,000 mark. After the high, the index slipped for three straight sessions, a clear reminder that volatility still has the upper hand. Meanwhile, the Indian rupee hit a fresh all-time low against the dollar last Friday. Fading hopes of a US Fed rate cut and slow progress on the India–US trade deal have kept up the pressure on the rupee.
Earnings season heats up, and superstar investors are smiling
By Tejas MD Profits are up in Q2 results — out of 267 companies in the Nifty 500 that have reported results, 166posted positivenet profit growth. Portfolio trackers are finally giving people something better than red arrows to look at. October was the best month for the Nifty 50 since March. But despite this, the index hasn't been able to break the psychological 26,000 barrier. It tried twice in October, stumbled both times, and now hovers below it, like a batsman stuck on 99 not out.
Analysts pick their winners: Five stocks set to shine in Q2FY26
By Tejas MD Just when you thought it was safe to check your portfolio, Donald Trump reclaimed his title as the market’s main character. It was a week of drama. On Friday, his tariff threat against China tanked the markets; by Monday, a breezy assurance of “All will be fine” sent them rallying back. All this played out in the wake of the Nobel Peace Prize announcement, an award everyone except Trump knew he wouldn't win. Volatility rules in 2025.
Bull run fizzles out: Multibagger count in Indian equities falls
By Tejas MD Almost a year has passed since the Nifty 50 touched its all-time high on September 27, 2024. Back then, the market looked unstoppable, breaking records week after week, and every investor felt like a stock-picking genius. A year later, the thrill is gone. The market has cooled, and investors check their portfolios the way Bangaloreans check traffic on Google Maps—cautiously, knowing it’s rarely good news.
A bull run in healthcare: Indian hospital stocks are beating the market
By Tejas MD Indian benchmark equities look flat over the past year. But the calm surface hides a turbulent story. Investors have been on a wild ride, dodging trade fights, tariff announcements, and worries about corporate earnings. The action wasn’t just in the market – political tensions are rising, and the news headlines recently exploded with Trump advisor Navarro’s bizarre claim that the Russia-Ukraine war was “Modi’s war”. The drama is far from over.
Superstar investors get bitten by volatility, ditch old favourites
By Tejas MD The sun has gone behind the clouds this August, and the stock market is feeling it. After the pain of July’s 2.9% drop, there was some early good news as Q1 earnings came in. But a news cycle filled with Trump threats has kept volatility up, and the momentum score for the Nifty right now is underwhelming. Still, one green signal keeps flashing: retail investors.
The twenty year winners among sectoral indices | Screener: Stocks with rising momentum
By Tejas MD Earnings season is underway, and no one is bursting fireworks yet. The early performance has been muted. Heavyweights such as Bajaj Finance and Kotak Mahindra Bank took hits after reporting disappointing results. On the other hand, Eternal (Zomato) surprised with good numbers, thanks to its quick commerce segment Blinkit growing rapidly, and the stock shot up. Overall, the mood on the street is not super upbeat.
Five winners from analysts: Stocks set to start FY26 with a bang | Screener: Stocks analysts are most bullish on
By Tejas MD We are in the week right before the first quarter results of FY26, when hopes are not yet dashed and anything is possible. The market has been stuck in neutral, awaiting early signals on results and the India-US trade deal. The deal has been stuck in the "it's almost there" stage for a while now. President Trump said that the India-US trade deal is “close” on July 7, even as the deadline for new tariffs quietly shifted from July 9 to August 1.
Winners and losers of 2025 in global indices | Screener: Nifty outperformers (so far) this year
By Tejas MD No one wants the news to be too interesting. But that's what has happened in 2025. After Trump's tariffs came the India-Pakistan conflict, and now it's the Iran-Israel war. It’s been a year where one should ask: "Who needs Netflix?" Just refresh the news page. Everyone praises the patient, long-term investor. And sure, patience may be a virtue, but these days it’s being tested everyday. How are the world’s major indices holding up in the storm?
What CEOs are saying about FY26 | Screener: Stocks gaining momentum after Q4 results
By Tejas MD Financial markets have a way of surprising you. Just when everyone was talking about the Nifty 50 being stuck in a correction, the index pulled a fast one, breaking through the psychological 25,000 mark on May 15 and now hovering around 5% of its all-time highs. A sharp 14% rebound from April lows is a reminder of how fast momentum can flip. Not everyone is celebrating yet.
Superstar investor portfolios take a hit from market volatility | Screener: Promoters reducing their stakes
By Tejas MD A diet that includes five cans of Coca Cola every day, potato chips and weekly meals at McDonald's. No exercise. This is the secret to Warren Buffett's longevity (he is now 94) and 75-year career. The famous Oracle of Omaha is retiring with a legacy that is difficult to imitate — whether in terms of his food habits, his success, or in the returns he generated at Berkshire Hathaway. Buffett's timeless quote,“Our favourite holding period is forever”, has inspired generations of investors.
Top five: Stocks that could outperform in upcoming results | Screener: Stocks with high durability scores, high target prices
By Tejas MD Does the tariff policy coming out of the US mean anything anymore? It seems pointless for markets to react to new announcements, since Trump could withdraw some tariffs in the morning and add new ones in the evening. Still, global equities got some breathing room after Trump hit pause on the latest round of tariffs. But don’t get too comfortable. US policy has become volatile, and dangers lurk around every corner.
Nifty Midcap is the winner among indices. But it's not without risks | Screener: Stocks that outperformed Q3, with strong estimates for next quarter
By Tejas MD The Indian stock market has been caught in a bear hug. The Nifty 50 is set to post losses for the fifth straight month—a trend we haven't seen since 1996. Unlike previous sharp corrections though, this downturn has been a slow bleed, with red ink drip-dripping across the charts every month. Just six months ago, the mood was very different. Markets were hitting record highs. It seemed like stocks could only go up.
Market correction hits superstar investor portfolios | Screener: Stocks with positive surprises in results
By Tejas MD Finance Minister Nirmala Sitharaman is probably not very happy with Tariff Man Donald Trump, considering how his tariff announcements stomped all over her Budget buzz. The Budget this year was a careful balancing act, with big income tax cuts for consumers as well as lower import duties to boost manufacturing. All this got eclipsed by Trump's tariff threats, and market chaos peaked on Sunday, as Nasdaq futures crashed 2.5%.
A turnaround for Indian pharma in the US | Screener: High momentum pharma stocks
By Tejas MD The fireworks were soggy for Indian markets in the new year. In the first 15 days of 2025, the Nifty 50 slipped into correction territory, down over 10% from its highs, while the Indian rupee tumbled to a record low, breaching 86 against the US dollar. According to Bloomberg, the mood will be muted this earnings season as well, as Q3FY25 results could bring a flurry of downgrades.
FIIs keep buying some sectors amid a broader selloff | Screener: Outperforming stocks with strong estimates for Q3
By Tejas MD For the last couple of years, India has basked in its status as a 'star performer' in the global economy, with strong growth even as China sputtered. But our article in October worried about signals that suggested that India's growth engine was slowing down. At the time, there was mostly anecdotal evidence from management about weak demand and consumer sentiment. But the latest GDP data has proved this beyond doubt.
Superstar investors turn cautious, shuffle their portfolios | Screener: Stocks in the PE buy zone with high target price upsides
By Tejas MD Indian equity markets initially celebrated Donald Trump’s win in the US presidential race, rising 1.1% on Nov 6—only to take a sharp U-turn the next day, falling 1.2% as investors took a closer look at his policy plans, which include aggressive tariffs on imports. Trump in his first term was a temperamental head of state, and he has already complained about India's trade policies: "India is very big with tariffs". Investors are in wait and watch mode this time around.
A DVM screener that outperforms the Nifty500 across all time frames | Screener: High momentum stocks with high volumes
By Tejas MD Just a month ago, the Indian equity markets looked hard to beat. The benchmarks were climbing new heights, defying gravity even as war spread in the Middle East and China struggled. The Nifty 50 blew past 26,000 in mid-September. Analysts highlighted India's rural recovery, and possible interest rate cuts. But in October, the sun went behind the clouds, and the Nifty 50 has slipped about 6.8% from its peak.
2024 becomes the 'Year of IPOs' | Screener: Newly listed stocks with rising revenue and profits in Q1
By Tejas MD When the tide rises, a lot of boats turn up to ride the wave. As Indian markets hit record highs, multiple companies - both SMEs and mainstream - have been launching IPOs on a near daily basis. According to Trendlyne’s IPO dashboard, 2024 has seen a record 204 companies list on the exchanges so far. Most of these companies are raising funds for expansion, working capital and to pay their debts.
Superstar investors on a selling spree as markets hit record highs | Screener: Promoters increase pledges in these stocks
By Tejas MD You know the experience of watching someone blow air into a balloon? They puff and puff and sometimes they keep going even when the balloon looks about to pop. That's what investors have been feeling, with the Indian indices. We've seen yet another all-time high for the Nifty 50 this week: the benchmark index has hit its all-time high for the eleventh week in a row. The bull run is now a full gallop, and the Nifty is within kissing distance of 25,000 as of this writing.
China is trying to win the global EV race | Screener: Auto stocks outperforming their sector
By Tejas MD Recently, Donald Trump made headlines in the media when he warned that there would be a ‘bloodbath’ if he lost the US elections. The bloodbath Trump was referring to? The threat American car companies face from Chinese auto players. Trump promised a 100% tariff on auto imports if he was elected. Foreign companies are convenient villains for politicians running for election. US President Biden and Donald Trump have been trying to outdo each other in sounding tough on China in particular.
The US dollar is beating the world's currencies | Screener: Export stocks with bullish analyst calls
By Tejas MD The US dollar is showing a lot of muscle in 2024. Every major currency in the world (including the Indian rupee) has depreciated versus the US dollar this year. Emerging markets are the hardest hit, but developed regions like Japan and Europe are also feeling the dollar's heat. On April 31, the Japanese yen fell below 160 yen to the dollar for the first time since 1990.
A valuation check on Nifty Smallcap, Midcap and Nifty50 | Screener: Stocks with strong analyst estimates ahead of Q4
By Tejas MD Even with the recent Nifty volatility, it has been a strong year for markets. And as inflation slows, hopes for interest rate cuts worldwide are rising, with many central bankers including Jerome Powell of the Fed and Andrew Bailey of the Bank of England hinting at the possibility. But the problem is that when central bankers whisper, the markets shout. … Subscriber exclusive for you. Click here to read. This is a premium article. Click here to read.
Which are the best and worst months for Indian stocks? | Screener: stocks outperforming their sectors
By Tejas MD The Nifty 50 has been on a dizzying ride. Last week saw yet another record high for the index, and it has hit new all-time highs over the past three weeks. The Nifty Smallcap 100 on the other hand, has declined for four consecutive weeks. Overall, the Nifty 50 has outperformed both small and mid-cap indices over the past month. This outperformance comes even as the regulator SEBI raised concerns about ‘froth’ building up in small and mid-cap stocks.
A rare opportunity: Can India gain from a fading China? | Screener: Outperforming export stocks
By Tejas MD India has long been seen as a country with massive “potential”, but far from realizing it. The one with both the talent and the red tape. The top colleges and high unemployment rates. Instead, our neighbour China was the one in the spotlight. But over the past many months, political and market factors have come together to favour India.
HDFC Bank sneezed, markets caught a cold | Screener: Promoters selling stocks
By Tejas MD As we head into the Republic Day weekend, a mixed results season has turned stock markets volatile. On January 17, the Sensex recorded its worst single-day decline in 18 months. The Bank Nifty had a particularly bad day, falling 4.3%, and HDFC Bank saw its biggest drop (-8.4%) since the Covid crash in 2020, on the back of its disappointing Q3FY24 results. HDFC Bank continued to fall earlier this week, dragging down the Bank Nifty.
2023 sees IPOs rebound, as investors grow optimistic
By Tejas MD The IPO market is a useful mirror, reflecting the mood of investors. In 2022, it showed caution and hesitation, but 2023 tells a different story – one of recovery. In 2022, high inflation and rising interest rates led to a quiet year for Indian IPOs. However, IPOs are back in fashion in 2023 as inflation eases to the RBI's target levels, and investor confidence rises. The benchmark Nifty 50 index is up 8.8% in 2023. This renewed enthusiasm is visible globally as well.
Seven stocks that beat expectations, despite global worries | Outperformers screener for Q2
By Tejas MD The earnings season is crunch time for equity markets, as investors and analysts compare the promises CEOs had made to actual results. But the Q2 season has been shadowed by concerns beyond balance sheets. Factors like rising oil prices due to the Israel-Hamas conflict, stubborn inflation, and the possibility of high interest rates sticking around for longer, have slowed market momentum.
The big winners: Five stocks expected to stand out in the Q2FY24 results season
By Tejas MD People woke up to shocking headlines on Saturday - an attack by Hamas within Israel that left more than a thousand people dead and several thousand wounded. It has led Israel to declare war on Gaza and cut off food, electricity and water supplies to the Palestinian region. The spiralling tensions have pushed oil prices higher, reminding us how interconnected global markets are.
US market comes back to life for Indian pharma | Screener: Outperforming pharma stocks
By Tejas MD After hitting its all-time high of 19,991.9 on July 20, the Nifty 50 index missed the much-anticipated 20K level by a sneeze and reversed course. The benchmark is now set to post a monthly loss in August – for the first time since February this year. due to El Nino and a fear of contagion from the shadow banking crisis in China dampened investor sentiment in August. The 20,000 mark remains elusive so far for the Nifty.
Four trends are changing the face of the Indian consumer
By Tejas MD In June this year, the US narrowly escaped a debt default, as its government made the deadline just in time to raise the debt ceiling. Now, the country's infamously high debt level (an eye-watering $32.7 trillion, 121.2% of its March 2023 GDP) is again in the news, after global rating agency Fitch downgraded the US credit rating to AA+ from AAA on August 2.
Bajaj, Hero come for Royal Enfield
By Tejas MD Michael Burry deletes his tweets, because he hates being wrong. But the investor, who became famous for predicting the 2008 financial crisis, is closely followed, and the media him in June 2022 warning investors about the coming stock market crash, which he had called “the mother of all crashes”. In March this year, Burry admitted he was wrong to tell investors to sell their stocks. In the ever-changing world of stock markets, narratives can quickly shift.
India gets a boost from foreign investors
By Tejas MD In the first two months of 2023, Indian indices fell around 4.5%. Market observers suggested that India was 'out' as the emerging market investors were betting on. The new favorites would be China and Taiwan. But fast forward to now, and there's been a remarkable recovery - the benchmark Nifty 50 index has risen over 9% from the year’s low, and now stands 3% away from its all-time high, which it hit in December last year. What is driving the momentum?
The New Oil: Shortages emerge in a key metal needed for EVs
By Tejas MD Sometimes it's hard to see how fast things are changing, until you take a step back. Look at transportation, for example. Electric vehicles used to be tiny, funny looking cars. Remember the Reva? Everything about the Reva was small - the battery life, mileage and leg room. You could sit in the backseat but not stretch your legs. In the last ten years however, electric vehicles have become expensive, futuristic, and can walk like a crab into a parking space.
Are Wipro's multiple share buybacks a bad idea?
Share buybacks have become a popular way for companies to reward their shareholders, particularly in the IT sector. However, like all expenses, a share repurchase has opportunity costs, which represent the potential benefits a company misses out on when choosing one option over another. Huge and consistent share buybacks for example, could signal that the company lacks new projects to invest its surplus cash in. Wipro has taken the buyback route often.
For Indian pharma, growth has got tougher with competition. But some players are rising to the task
By Tejas MD The pharmaceutical industry is a defensive sector, one that is expected to perform well even during market turmoil. Spending above a certain level remains steady, since a person’s health and medical care remains a priority irrespective of macroeconomic factors. As a result, drug makers have a beta considerably lower than 1 – their stock prices are less volatile than the … Subscriber exclusive for you. Click here to read. This is a premium article. Click here to read.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Tejas
Contact Tejas, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack